AstraZeneca said its cancer-treatment drugs when used following chemotherapy treatment showed positive late-stage trial results for endometrial cancer patients.
Share:
More In Business
First Robotaxi Fleet Hits Austin Streets—Regulators, Riders React
Al Root, Associate Editor at Barron's, joins to discuss Tesla’s robotaxis going live in Texas—what it means for autonomy, safety, and the EV race ahead.
Mid‑Market vs. Mega‑Deals: Which Segment Will Shape 2025’s M&A Landscape?
Dena Jalbert, M&A expert and CEO of Align Business Advisory Services, on the state of U.S. M&A: deals worth $1–$10 billion (including debt) are surging.
Consumers Expect to Curb Summer Fun—But Spending Tells a Different Story
Ted Rossman, Senior Industry Analyst at Bankrate, joins J.D. Durkin to discuss the disconnect between consumer sentiment and spending. Watch!
Are U.S.-China Trade Relations Showing Improvement?
Jeremy Jansen, Head of Supply Chain at Wells Fargo, unpacks the ongoing trade talks between the United States and China as consumers still wonder about tariffs.
Texas lawmakers try to throw a wrench into Elon Musk’s robotaxi debut
A group of Democratic Texas lawmakers is asking Elon Musk to delay his rollout of driverless ‘robotaxis’ in the state this weekend to assure the vehicles are safe enough.
How the Lakers’ new owner made his fortune
The billionaire slated to takeover the controlling interest in the Los Angeles Lakers has built a career leading businesses investing in everything from sports franchises to artificial intelligence.
IBM Gears Up for First Quantum‑Centric Supercomputer in 2025
IBM Fellow Jerry Chow talks IBM’s expansion of the Quantum Data Center in Poughkeepsie, installing Heron processors that deliver utility‑scale performance.
Big Business This Week: Market Is A Big Fan of Turbines
DNA firm is back under old management, Meta is poaching AI talent, TikTok's deadline looms, Kraft goes natural with dyes, and WhatsApp introduces ads.
New Amazon factory aims to deliver 10,000 robotaxis annually
Amazon is gearing up to make as 10,000 robotaxis annually at a sprawling plant near Silicon Valley.
